MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announces the publication of preclinical data for ...

Research indicates that melatonin, known for regulating sleep, may enhance DNA repair processes in individuals with disrupted sleep patterns.

Melatonin supplementation was linked to borderline significant increase in an indicator of oxidative DNA damage repair capacity.

Ateganosine, also known as 6-thio-2'-deoxyguanosine, works by inducing telomerase-dependent telomeric DNA modification and activating immune responses, including the innate cGAS/STING pathway and ...

Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small ...

Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung ...

Researchers analyzed their urine samples to measure levels of a marker called 8-hydroxy-2′-deoxyguanosine (8-OH-dG). This ...

Supplements were consumed before day sleep during a four-week period. Creatinine-adjusted 8-hydroxy-2'-deoxyguanosine (8-OH-dG) measured in urine was an indicator of oxidative DNA damage repair ...

During that time, the researchers took urine samples and measured for something called creatinine-adjusted 8-hydroxy-2′-deoxyguanosine (8-OH-dG) to look for the body’s capacity to perform ...